Cerespectus and Vasowatch Join HiveBio’s Inaugural Cohort
HiveBio has selected its inaugural cohort of underrepresented biotech founders.
Cerespectus Accepted into Science Center’s Capital Readiness Program
Cerespectus was co-founded by Bryan Pukenas, MD, Associate Professor of Radiology in Penn Medicine.
MavriX Bio Announces FDA Clearance for Gene Therapy Trial
MavriX will initiate a clinical trial of a gene therapy for Angelman syndrome.
Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Autoimmune Disease
Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.
REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Penn Startup Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
AI Across Disciplines Event Highlights Penn’s Role in Shaping AI
At a cross-disciplinary gathering at Amy Gutmann Hall, the Penn community celebrated the launch of the Penn AI Initiative with a panel discussing AI research at Penn.
Academic Entrepreneurship the Focus of Recent Speaker Series
Bryan presented on "Software as a Medical Device” and shared his journey co-founding Galileo CDS.
Penn’s Jake Brenner Develops State-of-the-art DNA-Delivery Technology
By safely delivering therapeutic DNA to cells, this technology has the potential to transform treatment for common chronic diseases.